By conducting pathway enrichment analyses on genes involved in specific cancer risk prediction models, such as lung cancer, CRPMKB helps identify significant pathways like p53 signaling and aryl hydrocarbon receptor signaling, aiding in understanding the biological mechanisms underlying cancer development. Here, TP53 is linked to cancer.